A detailed history of Strs Ohio transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Strs Ohio holds 6,200 shares of BPMC stock, worth $568,044. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,200
Previous 7,500 17.33%
Holding current value
$568,044
Previous $808,000 29.08%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$84.1 - $120.5 $109,329 - $156,650
-1,300 Reduced 17.33%
6,200 $573,000
Q2 2024

Aug 05, 2024

BUY
$85.18 - $108.78 $153,324 - $195,804
1,800 Added 31.58%
7,500 $808,000
Q1 2024

May 13, 2024

SELL
$73.17 - $99.79 $80,487 - $109,769
-1,100 Reduced 16.18%
5,700 $540,000
Q4 2023

Jan 30, 2024

BUY
$43.96 - $92.84 $145,068 - $306,372
3,300 Added 94.29%
6,800 $627,000
Q3 2023

Oct 26, 2023

SELL
$46.9 - $66.0 $65,660 - $92,400
-1,400 Reduced 28.57%
3,500 $175,000
Q2 2023

Jul 31, 2023

BUY
$42.2 - $66.37 $113,940 - $179,199
2,700 Added 122.73%
4,900 $309,000
Q1 2023

Aug 02, 2023

SELL
$37.97 - $50.0 $102,519 - $135,000
-2,700 Reduced 55.1%
2,200 $98,000
Q1 2023

Apr 27, 2023

BUY
$37.97 - $50.0 $11,391 - $15,000
300 Added 15.79%
2,200 $98,000
Q4 2022

Jan 26, 2023

SELL
$41.06 - $66.48 $164,240 - $265,920
-4,000 Reduced 67.8%
1,900 $83,000
Q3 2022

Oct 27, 2022

BUY
$49.93 - $77.7 $94,867 - $147,630
1,900 Added 47.5%
5,900 $388,000
Q2 2022

Jul 25, 2022

SELL
$45.23 - $70.15 $131,167 - $203,435
-2,900 Reduced 42.03%
4,000 $202,000
Q4 2021

Jan 24, 2022

SELL
$94.25 - $115.99 $65,975 - $81,193
-700 Reduced 9.21%
6,900 $739,000
Q3 2021

Oct 22, 2021

SELL
$80.98 - $109.47 $64,784 - $87,576
-800 Reduced 9.52%
7,600 $781,000
Q2 2021

Jul 26, 2021

BUY
$82.78 - $101.0 $66,224 - $80,800
800 Added 10.53%
8,400 $738,000
Q1 2021

Apr 23, 2021

SELL
$90.71 - $108.28 $653,112 - $779,616
-7,200 Reduced 48.65%
7,600 $738,000
Q4 2020

Jan 25, 2021

BUY
$92.08 - $124.48 $699,808 - $946,048
7,600 Added 105.56%
14,800 $1.66 Million
Q3 2020

Dec 14, 2020

SELL
$66.45 - $92.7 $66,450 - $92,700
-1,000 Reduced 12.2%
7,200 $667,000
Q2 2020

Jul 23, 2020

BUY
$57.09 - $79.27 $34,254 - $47,562
600 Added 7.89%
8,200 $639,000
Q1 2020

Apr 23, 2020

BUY
$48.11 - $82.22 $96,220 - $164,440
2,000 Added 35.71%
7,600 $444,000
Q4 2019

Jan 24, 2020

SELL
$66.73 - $82.59 $120,114 - $148,662
-1,800 Reduced 24.32%
5,600 $448,000
Q2 2019

Jul 25, 2019

BUY
$73.54 - $97.8 $205,912 - $273,840
2,800 Added 60.87%
7,400 $698,000
Q1 2019

Apr 19, 2019

BUY
$48.7 - $86.6 $73,050 - $129,899
1,500 Added 48.39%
4,600 $368,000
Q4 2018

Jan 23, 2019

SELL
$45.57 - $74.26 $13,671 - $22,278
-300 Reduced 8.82%
3,100 $167,000
Q3 2018

Oct 19, 2018

SELL
$58.91 - $78.32 $182,621 - $242,791
-3,100 Reduced 47.69%
3,400 $265,000
Q2 2018

Aug 06, 2018

BUY
$60.96 - $101.18 $36,576 - $60,708
600 Added 10.17%
6,500 $412,000
Q1 2018

Apr 20, 2018

BUY
$73.28 - $102.95 $146,560 - $205,900
2,000 Added 51.28%
5,900 $541,000
Q4 2017

Jan 23, 2018

BUY
$62.91 - $88.32 $100,656 - $141,312
1,600 Added 69.57%
3,900 $294,000
Q3 2017

Oct 23, 2017

BUY
$42.37 - $69.67 $97,451 - $160,241
2,300
2,300 $160,000

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.47B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.